Innovation in Immunoassay Development 

Use of Dynamic in silico Protein Structure in the development of a biomaterial for the IVD Industry   

When developing a new immunoassay, having a deep knowledge of the biomaterial helps to optimize R&D resources.  And what’s more, it helps reduce the risk in later stages of the project, where significant commitments are made and the cost of responding to unexpected events increases exponentially. 

Join us in the OEM series to hear how by dynamic in silico and functional analysis we can gain knowledge of the biomaterial to de-risk in later stages of the project.